person · Reporting owner

PUHY DOROTHY E

Disclosed activity across 4 companies

Tapewire entity: 38673
SEC CIK: 0001200493

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Azenta, Inc.AZTA · Entity 4724	Director	February 13, 2023	February 15, 2023
MIMEDX GROUP, INC.MDXG · Entity 5271	Director	June 10, 2026	June 12, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Azenta, Inc.

Report date February 13, 2023 · Filed February 15, 2023

Security / award	Ownership account	Disclosed shares / units	Disclosure context
CommonSEC Table I · non-derivative	Direct	3,604	Reported balance After 2023-02-13 transaction · row 1 1 source row Row 1 · 2023-02-13 · Grant · Acquired 3,604 · Balance 3,604 F1: Grant of unrestricted shares under the company's 2020 Equity Incentive Plan. No amount was paid upon grant of the shares.

Filing footnotes · ownership attribution and instrument terms

F1: Grant of unrestricted shares under the company's 2020 Equity Incentive Plan. No amount was paid upon grant of the shares.

MIMEDX GROUP, INC.

Report date June 10, 2026 · Filed June 12, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	108,510	Reported balance After 2026-06-10 transaction · row 1 1 source row Row 1 · 2026-06-10 · Grant · Acquired 50,913 · Balance 108,510 F1: Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next meeting of shareholders.

Filing footnotes · ownership attribution and instrument terms

F1: Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next meeting of shareholders.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

ABIOMED INC

Report date December 22, 2022 · Filed December 27, 2022

Section 16 reporting ended · disclosed 2022-12-27. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common Stock, $0.01 par valueSEC Table I · non-derivative	Direct	0	Reported balance After 2022-12-22 transaction · row 1 Sequence does not reconcile; account continuity is unresolved. 1 source row Row 1 · 2022-12-22 · Disposition to issuer · Disposed 3,255 · Balance 0 F1: Disposed in connection with transactions contemplated by the Agreement and Plan of Merger, dated as of October 31, 2022 (the "Merger Agreement"), by and among the Issuer, Johnson & Johnson ("Parent") and Athos Merger Sub, Inc. ("Merger Sub"), pursuant to which Merger Sub was merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. As a result of the Merger, each outstanding share of common stock, par value $0.01 per share, of the Issuer (the "Issuer Share") was automatically converted into the right to receive (i) an amount in cash equal to $380.00 (the "Cash Amount"), plus (ii) one non-tradeable contingent value right (the "CVR"), representing the right to receive contingent payments of up to $35.00 per Issuer Share, payable upon the achievement of certain specified milestones set out in the Contingent Value Rights Agreement. F2: Pursuant to the Merger Agreement, each award of restricted stock units, excluding any award of restricted stock units with vesting subject to performance-based conditions ("Company RSU Award"), outstanding as of immediately prior to the effective time of the Merger (the "Effective Time") was canceled and converted into the right to receive (i) an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Company RSU Award and (B) the Cash Amount and (ii) one CVR per Issuer Share underlying such Company RSU Award immediately prior to the Effective Time. F3: Reflects the correction of an immaterial error in the balance reported in the reporting person's Form 4 filed on August 12, 2022.
Common Stock, $0.01 par valueSEC Table I · non-derivative	Direct	0	Reported balance After 2022-12-22 transaction · row 2 Sequence does not reconcile; account continuity is unresolved. 1 source row Row 2 · 2022-12-22 · Disposition to issuer · Disposed 11,335 · Balance 0 F1: Disposed in connection with transactions contemplated by the Agreement and Plan of Merger, dated as of October 31, 2022 (the "Merger Agreement"), by and among the Issuer, Johnson & Johnson ("Parent") and Athos Merger Sub, Inc. ("Merger Sub"), pursuant to which Merger Sub was merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. As a result of the Merger, each outstanding share of common stock, par value $0.01 per share, of the Issuer (the "Issuer Share") was automatically converted into the right to receive (i) an amount in cash equal to $380.00 (the "Cash Amount"), plus (ii) one non-tradeable contingent value right (the "CVR"), representing the right to receive contingent payments of up to $35.00 per Issuer Share, payable upon the achievement of certain specified milestones set out in the Contingent Value Rights Agreement.

Filing footnotes · ownership attribution and instrument terms

F1: Disposed in connection with transactions contemplated by the Agreement and Plan of Merger, dated as of October 31, 2022 (the "Merger Agreement"), by and among the Issuer, Johnson & Johnson ("Parent") and Athos Merger Sub, Inc. ("Merger Sub"), pursuant to which Merger Sub was merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. As a result of the Merger, each outstanding share of common stock, par value $0.01 per share, of the Issuer (the "Issuer Share") was automatically converted into the right to receive (i) an amount in cash equal to $380.00 (the "Cash Amount"), plus (ii) one non-tradeable contingent value right (the "CVR"), representing the right to receive contingent payments of up to $35.00 per Issuer Share, payable upon the achievement of certain specified milestones set out in the Contingent Value Rights Agreement.

F2: Pursuant to the Merger Agreement, each award of restricted stock units, excluding any award of restricted stock units with vesting subject to performance-based conditions ("Company RSU Award"), outstanding as of immediately prior to the effective time of the Merger (the "Effective Time") was canceled and converted into the right to receive (i) an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Company RSU Award and (B) the Cash Amount and (ii) one CVR per Issuer Share underlying such Company RSU Award immediately prior to the Effective Time.

F3: Reflects the correction of an immaterial error in the balance reported in the reporting person's Form 4 filed on August 12, 2022.

Mirror Merger Sub 2, LLC

Report date March 01, 2021 · Filed March 03, 2021

Section 16 reporting ended · disclosed 2021-03-03. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Eaton Vance Corp. Non-voting Common StockSEC Table I · non-derivative	Direct	Reported balance After 2021-03-01 transaction · row 1 1 source row Row 1 · 2021-03-01 · Disposition to issuer · Disposed 23,981 · Balance 0 F1: Disposed of pursuant to the Agreement and Plan of Merger, dated as of October 7, 2020 (the Merger Agreement), by and among Issuer, Morgan Stanley, Mirror Merger Sub 1, Inc. and Mirror Merger Sub 2, LLC, in exchange for $1,750,613.00.
Deferred StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	Reported balance After 2021-03-01 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2021-03-01 · Disposition to issuer · Disposed 9,372 · Balance 0 F2: Each Deferred Stock Unit is the economic equivalent of one share of non-voting common stock. F3: This Deferred Stock Unit award was canceled and converted in the Merger into the right to receive a cash payment of $73 per share for a total of $684,156.00.
Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $28.23 · Expires 2022-11-01	Direct	Reported balance After 2021-03-01 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2021-03-01 · Disposition to issuer · Disposed 5,680 · Balance 0 F4: This option award, which was granted on November 1, 2012, was canceled and converted in the Merger into the right to receive a cash payment of $73 per share for a total of $254,310.13.
Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $36.76 · Expires 2025-11-02	Direct	Reported balance After 2021-03-01 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2021-03-01 · Disposition to issuer · Disposed 7,451 · Balance 0 F5: This option award, which was granted on November 2, 2015, was canceled and converted in the Merger into the right to receive a cash payment of $73 per share for a total of $270,024.24.
Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $36.71 · Expires 2024-11-03	Direct	Reported balance After 2021-03-01 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2021-03-01 · Disposition to issuer · Disposed 5,737 · Balance 0 F6: This option award, which was granted on November 3, 2014, was canceled and converted in the Merger into the right to receive a cash payment of $73 per share for a total of $208,195.73.
Phantom StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	Reported balance After 2021-03-01 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2021-03-01 · Disposition to issuer · Disposed 3,252 · Balance 0 F7: Each Phantom Stock Unit is the economic equivalent of one share of non-voting common stock. F8: This Phantom Stock Unit award, which was granted on November 1, 2017, was canceled and converted in the Merger into the right to receive a cash payment of $73 per share for a total of $237,396.00.

Filing footnotes · ownership attribution and instrument terms

F1: Disposed of pursuant to the Agreement and Plan of Merger, dated as of October 7, 2020 (the Merger Agreement), by and among Issuer, Morgan Stanley, Mirror Merger Sub 1, Inc. and Mirror Merger Sub 2, LLC, in exchange for $1,750,613.00.

F2: Each Deferred Stock Unit is the economic equivalent of one share of non-voting common stock.

F3: This Deferred Stock Unit award was canceled and converted in the Merger into the right to receive a cash payment of $73 per share for a total of $684,156.00.

F4: This option award, which was granted on November 1, 2012, was canceled and converted in the Merger into the right to receive a cash payment of $73 per share for a total of $254,310.13.

F5: This option award, which was granted on November 2, 2015, was canceled and converted in the Merger into the right to receive a cash payment of $73 per share for a total of $270,024.24.

F6: This option award, which was granted on November 3, 2014, was canceled and converted in the Merger into the right to receive a cash payment of $73 per share for a total of $208,195.73.

F7: Each Phantom Stock Unit is the economic equivalent of one share of non-voting common stock.

F8: This Phantom Stock Unit award, which was granted on November 1, 2017, was canceled and converted in the Merger into the right to receive a cash payment of $73 per share for a total of $237,396.00.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
June 10, 2026 Filed Jun 12, 2026 15:35 UTC	MIMEDX GROUP, INC. MDXG · Entity 5271	GrantCommon Stock	50,913	$3.64	$185,323.32	Disclosure SEC source: 0001376339-26-000047 · wk-form4_1781278523.xml · nonDerivative · entry 1 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,510 F1 · shares: Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next meeting of shareholders. Read SEC document
June 18, 2025 Filed Jun 23, 2025 22:31 UTC	MIMEDX GROUP, INC. MDXG · Entity 5271	GrantCommon Stock	28,609	$6.47	$185,100.23	Disclosure SEC source: 0001376339-25-000061 · wk-form4_1750717856.xml · nonDerivative · entry 1 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,597 F1 · shares: Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next annual meeting of shareholders Read SEC document
June 05, 2024 Filed Jun 6, 2024 20:14 UTC	MIMEDX GROUP, INC. MDXG · Entity 5271	GrantCommon Stock	28,988	$7.26	$210,452.88	Disclosure SEC source: 0001376339-24-000044 · wk-form4_1717704830.xml · nonDerivative · entry 1 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,988 F1 · shares: Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next annual meeting of shareholders. Read SEC document
February 13, 2023 Filed Feb 15, 2023 21:20 UTC	Azenta, Inc. AZTA · Entity 4724	GrantCommon	3,604	$0.00	$0.00	Disclosure SEC source: 0001209191-23-009727 · doc4.xml · nonDerivative · entry 1 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,604 F1 · price: Grant of unrestricted shares under the company's 2020 Equity Incentive Plan. No amount was paid upon grant of the shares. Read SEC document
December 22, 2022 Filed Dec 27, 2022 20:44 UTC	ABIOMED INC NASD · Entity 121309	Disposition to issuerCommon Stock, $0.01 par value	11,335	$0.00	$0.00	Disclosure SEC source: 0001415889-22-013031 · form4-12282022_011224.xml · nonDerivative · entry 2 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Disposed in connection with transactions contemplated by the Agreement and Plan of Merger, dated as of October 31, 2022 (the "Merger Agreement"), by and among the Issuer, Johnson & Johnson ("Parent") and Athos Merger Sub, Inc. ("Merger Sub"), pursuant to which Merger Sub was merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. As a result of the Merger, each outstanding share of common stock, par value $0.01 per share, of the Issuer (the "Issuer Share") was automatically converted into the right to receive (i) an amount in cash equal to $380.00 (the "Cash Amount"), plus (ii) one non-tradeable contingent value right (the "CVR"), representing the right to receive contingent payments of up to $35.00 per Issuer Share, payable upon the achievement of certain specified milestones set out in the Contingent Value Rights Agreement. F1 · shares: Disposed in connection with transactions contemplated by the Agreement and Plan of Merger, dated as of October 31, 2022 (the "Merger Agreement"), by and among the Issuer, Johnson & Johnson ("Parent") and Athos Merger Sub, Inc. ("Merger Sub"), pursuant to which Merger Sub was merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. As a result of the Merger, each outstanding share of common stock, par value $0.01 per share, of the Issuer (the "Issuer Share") was automatically converted into the right to receive (i) an amount in cash equal to $380.00 (the "Cash Amount"), plus (ii) one non-tradeable contingent value right (the "CVR"), representing the right to receive contingent payments of up to $35.00 per Issuer Share, payable upon the achievement of certain specified milestones set out in the Contingent Value Rights Agreement. F1 · price: Disposed in connection with transactions contemplated by the Agreement and Plan of Merger, dated as of October 31, 2022 (the "Merger Agreement"), by and among the Issuer, Johnson & Johnson ("Parent") and Athos Merger Sub, Inc. ("Merger Sub"), pursuant to which Merger Sub was merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. As a result of the Merger, each outstanding share of common stock, par value $0.01 per share, of the Issuer (the "Issuer Share") was automatically converted into the right to receive (i) an amount in cash equal to $380.00 (the "Cash Amount"), plus (ii) one non-tradeable contingent value right (the "CVR"), representing the right to receive contingent payments of up to $35.00 per Issuer Share, payable upon the achievement of certain specified milestones set out in the Contingent Value Rights Agreement. Read SEC document
December 22, 2022 Filed Dec 27, 2022 20:44 UTC	ABIOMED INC NASD · Entity 121309	Disposition to issuerCommon Stock, $0.01 par value	3,255	$0.00	$0.00	Disclosure SEC source: 0001415889-22-013031 · form4-12282022_011224.xml · nonDerivative · entry 1 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Disposed in connection with transactions contemplated by the Agreement and Plan of Merger, dated as of October 31, 2022 (the "Merger Agreement"), by and among the Issuer, Johnson & Johnson ("Parent") and Athos Merger Sub, Inc. ("Merger Sub"), pursuant to which Merger Sub was merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. As a result of the Merger, each outstanding share of common stock, par value $0.01 per share, of the Issuer (the "Issuer Share") was automatically converted into the right to receive (i) an amount in cash equal to $380.00 (the "Cash Amount"), plus (ii) one non-tradeable contingent value right (the "CVR"), representing the right to receive contingent payments of up to $35.00 per Issuer Share, payable upon the achievement of certain specified milestones set out in the Contingent Value Rights Agreement. F2 · kind: Pursuant to the Merger Agreement, each award of restricted stock units, excluding any award of restricted stock units with vesting subject to performance-based conditions ("Company RSU Award"), outstanding as of immediately prior to the effective time of the Merger (the "Effective Time") was canceled and converted into the right to receive (i) an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Company RSU Award and (B) the Cash Amount and (ii) one CVR per Issuer Share underlying such Company RSU Award immediately prior to the Effective Time. F1 · shares: Disposed in connection with transactions contemplated by the Agreement and Plan of Merger, dated as of October 31, 2022 (the "Merger Agreement"), by and among the Issuer, Johnson & Johnson ("Parent") and Athos Merger Sub, Inc. ("Merger Sub"), pursuant to which Merger Sub was merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. As a result of the Merger, each outstanding share of common stock, par value $0.01 per share, of the Issuer (the "Issuer Share") was automatically converted into the right to receive (i) an amount in cash equal to $380.00 (the "Cash Amount"), plus (ii) one non-tradeable contingent value right (the "CVR"), representing the right to receive contingent payments of up to $35.00 per Issuer Share, payable upon the achievement of certain specified milestones set out in the Contingent Value Rights Agreement. F2 · shares: Pursuant to the Merger Agreement, each award of restricted stock units, excluding any award of restricted stock units with vesting subject to performance-based conditions ("Company RSU Award"), outstanding as of immediately prior to the effective time of the Merger (the "Effective Time") was canceled and converted into the right to receive (i) an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Company RSU Award and (B) the Cash Amount and (ii) one CVR per Issuer Share underlying such Company RSU Award immediately prior to the Effective Time. F3 · shares: Reflects the correction of an immaterial error in the balance reported in the reporting person's Form 4 filed on August 12, 2022. F1 · price: Disposed in connection with transactions contemplated by the Agreement and Plan of Merger, dated as of October 31, 2022 (the "Merger Agreement"), by and among the Issuer, Johnson & Johnson ("Parent") and Athos Merger Sub, Inc. ("Merger Sub"), pursuant to which Merger Sub was merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. As a result of the Merger, each outstanding share of common stock, par value $0.01 per share, of the Issuer (the "Issuer Share") was automatically converted into the right to receive (i) an amount in cash equal to $380.00 (the "Cash Amount"), plus (ii) one non-tradeable contingent value right (the "CVR"), representing the right to receive contingent payments of up to $35.00 per Issuer Share, payable upon the achievement of certain specified milestones set out in the Contingent Value Rights Agreement. F2 · price: Pursuant to the Merger Agreement, each award of restricted stock units, excluding any award of restricted stock units with vesting subject to performance-based conditions ("Company RSU Award"), outstanding as of immediately prior to the effective time of the Merger (the "Effective Time") was canceled and converted into the right to receive (i) an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Company RSU Award and (B) the Cash Amount and (ii) one CVR per Issuer Share underlying such Company RSU Award immediately prior to the Effective Time. Read SEC document
August 11, 2022 Filed Aug 12, 2022 16:18 UTC	ABIOMED INC NASD · Entity 121309	Tax withholdingCommon Stock, $0.01 par value	263	$293.34	$77,148.42	Disclosure SEC source: 0001415889-22-008540 · form4-08122022_010823.xml · nonDerivative · entry 2 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,633 F2 · kind: Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards. F2 · shares: Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards. Read SEC document
August 10, 2022 Filed Aug 12, 2022 16:18 UTC	ABIOMED INC NASD · Entity 121309	GrantCommon Stock, $0.01 par value	681	$0.00	$0.00	Disclosure SEC source: 0001415889-22-008540 · form4-08122022_010823.xml · nonDerivative · entry 1 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,896 F1 · kind: Represents shares underlying the grant of restricted stock units that are to be settled in common stock upon vesting. The restricted stock units will vest in full on the earlier of: (a) the first anniversary of the date of grant; and (b) the date of the Corporation's 2023 Annual Meeting; that such awards shall be subject to a Time-Based Restricted Stock Unit Award Agreement in accordance with the Second Amended & Restated 2015 Omnibus Incentive Plan F1 · shares: Represents shares underlying the grant of restricted stock units that are to be settled in common stock upon vesting. The restricted stock units will vest in full on the earlier of: (a) the first anniversary of the date of grant; and (b) the date of the Corporation's 2023 Annual Meeting; that such awards shall be subject to a Time-Based Restricted Stock Unit Award Agreement in accordance with the Second Amended & Restated 2015 Omnibus Incentive Plan Read SEC document
August 12, 2021 Filed Aug 13, 2021 16:36 UTC	ABIOMED INC ABMD · Entity 121309	Tax withholdingCommon Stock, $0.01 par value	279	$319.88	$89,246.52	Disclosure SEC source: 0001179110-21-008181 · edgar.xml · nonDerivative · entry 2 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,215 F2 · kind: Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards. F2 · shares: Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards. Read SEC document
August 11, 2021 Filed Aug 13, 2021 16:36 UTC	ABIOMED INC ABMD · Entity 121309	GrantCommon Stock, $0.01 par value	625	$0.00	$0.00	Disclosure SEC source: 0001179110-21-008181 · edgar.xml · nonDerivative · entry 1 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,494 F1 · kind: Represents shares underlying the grant of restricted stock units that are to be settled in common stock upon vesting. The restricted stock units will vest in full on the earlier of: (a)August 11, 2022; or (b) the date of the Issuer's next annual meeting of stockholders. F1 · shares: Represents shares underlying the grant of restricted stock units that are to be settled in common stock upon vesting. The restricted stock units will vest in full on the earlier of: (a)August 11, 2022; or (b) the date of the Issuer's next annual meeting of stockholders. Read SEC document
March 01, 2021 Filed Mar 3, 2021 17:28 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	Disposition to issuerPhantom Stock · Derivative	3,252	$73.00 Strike: $0.00	$237,396.00	Disclosure SEC source: 0001225208-21-004553 · doc4.xml · derivative · entry 6 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Eaton Vance Corp. Non-voting Common Stock · 3,252 shares Expires not disclosed F7 · security: Each Phantom Stock Unit is the economic equivalent of one share of non-voting common stock. F8 · price: This Phantom Stock Unit award, which was granted on November 1, 2017, was canceled and converted in the Merger into the right to receive a cash payment of $73 per share for a total of $237,396.00. F8 · derivative.exercise_date: This Phantom Stock Unit award, which was granted on November 1, 2017, was canceled and converted in the Merger into the right to receive a cash payment of $73 per share for a total of $237,396.00. F8 · derivative.expiration_date: This Phantom Stock Unit award, which was granted on November 1, 2017, was canceled and converted in the Merger into the right to receive a cash payment of $73 per share for a total of $237,396.00. Read SEC document
March 01, 2021 Filed Mar 3, 2021 17:28 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	Disposition to issuerOption (right to buy) · Derivative	5,737	$36.29 Strike: $36.71	$208,195.73	Disclosure SEC source: 0001225208-21-004553 · doc4.xml · derivative · entry 5 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Eaton Vance Corp. Non-voting Common Stock · 5,737 shares Expires 2024-11-03 F6 · price: This option award, which was granted on November 3, 2014, was canceled and converted in the Merger into the right to receive a cash payment of $73 per share for a total of $208,195.73. Read SEC document
March 01, 2021 Filed Mar 3, 2021 17:28 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	Disposition to issuerOption (right to buy) · Derivative	7,451	$36.24 Strike: $36.76	$270,024.24	Disclosure SEC source: 0001225208-21-004553 · doc4.xml · derivative · entry 4 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Eaton Vance Corp. Non-voting Common Stock · 7,451 shares Expires 2025-11-02 F5 · price: This option award, which was granted on November 2, 2015, was canceled and converted in the Merger into the right to receive a cash payment of $73 per share for a total of $270,024.24. Read SEC document
March 01, 2021 Filed Mar 3, 2021 17:28 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	Disposition to issuerOption (right to buy) · Derivative	5,680	$44.77 Strike: $28.23	$254,310.64	Disclosure SEC source: 0001225208-21-004553 · doc4.xml · derivative · entry 3 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Eaton Vance Corp. Non-voting Common Stock · 5,680 shares Expires 2022-11-01 F4 · price: This option award, which was granted on November 1, 2012, was canceled and converted in the Merger into the right to receive a cash payment of $73 per share for a total of $254,310.13. Read SEC document
March 01, 2021 Filed Mar 3, 2021 17:28 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	Disposition to issuerDeferred Stock · Derivative	9,372	$73.00 Strike: $0.00	$684,156.00	Disclosure SEC source: 0001225208-21-004553 · doc4.xml · derivative · entry 2 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Eaton Vance Corp. Non-voting Common Stock · 9,372 shares Expires not disclosed F2 · security: Each Deferred Stock Unit is the economic equivalent of one share of non-voting common stock. F3 · price: This Deferred Stock Unit award was canceled and converted in the Merger into the right to receive a cash payment of $73 per share for a total of $684,156.00. F3 · derivative.exercise_date: This Deferred Stock Unit award was canceled and converted in the Merger into the right to receive a cash payment of $73 per share for a total of $684,156.00. F3 · derivative.expiration_date: This Deferred Stock Unit award was canceled and converted in the Merger into the right to receive a cash payment of $73 per share for a total of $684,156.00. Read SEC document
March 01, 2021 Filed Mar 3, 2021 17:28 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	Disposition to issuerEaton Vance Corp. Non-voting Common Stock	23,981	$0.00	$0.00	Disclosure SEC source: 0001225208-21-004553 · doc4.xml · nonDerivative · entry 1 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Disposed of pursuant to the Agreement and Plan of Merger, dated as of October 7, 2020 (the Merger Agreement), by and among Issuer, Morgan Stanley, Mirror Merger Sub 1, Inc. and Mirror Merger Sub 2, LLC, in exchange for $1,750,613.00. Read SEC document
February 12, 2021 Filed Feb 16, 2021 17:33 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	GrantPhantom Stock · Derivative	17	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-21-002527 · doc4.xml · derivative · entry 3 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,252 Underlying: Eaton Vance Corp. Non-voting Common Stock · 17 shares Expires not disclosed F4 · security: Each share of Phantom Stock is the economic equivalent of one share of non-voting common stock. F5 · shares: As dividends are paid with respect to Company Non-Voting Common Stock, a number of units of Phantom Stock with a current value equal to the amount of the dividend will be allocated to the account of each non-employee Director with respect to each unit of Phantom Stock Awarded at the time such dividends are paid to the stock holders of the Company. F6 · derivative.exercise_date: The shares of Phantom Stock granted on November 1, 2017 become payable in cash upon the non-employee director's termination. F6 · derivative.expiration_date: The shares of Phantom Stock granted on November 1, 2017 become payable in cash upon the non-employee director's termination. Read SEC document
February 12, 2021 Filed Feb 16, 2021 17:33 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	GrantDeferred Stock · Derivative	50	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-21-002527 · doc4.xml · derivative · entry 2 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,372 Underlying: Eaton Vance Corp. Non-voting Common Stock · 50 shares Expires not disclosed F1 · security: Each share of Deferred Stock is the economic equivalent of one share of non-voting common stock. F2 · shares: As dividends are paid with respect to Company Non-Voting Common Stock, a number of units of Deferred Stock with a current value equal to the amount of the dividend will be allocated to the account of each non-employee Director with respect to each unit of Deferred Stock Awarded at the time such dividends are paid to the stock holders of the Company. F3 · derivative.exercise_date: Shares of Deferred Stock become payable in cash based on the non-employee director's election at either (1) the earlier of the second anniversary of the grant date or the date of the non-employee director's termination, or (2) upon the non-employee director's termination. F3 · derivative.expiration_date: Shares of Deferred Stock become payable in cash based on the non-employee director's election at either (1) the earlier of the second anniversary of the grant date or the date of the non-employee director's termination, or (2) upon the non-employee director's termination. Read SEC document
February 01, 2021 Filed Feb 3, 2021 17:03 UTC	ABIOMED INC ABMD · Entity 121309	SaleCommon Stock, $0.01 par value	201	$353.07	$70,967.07	Disclosure SEC source: 0001179110-21-001224 · edgar.xml · nonDerivative · entry 4 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,869 F1 · kind: Sale of common stock pursuant to reporting owner's 10b5-1 plan. F1 · shares: Sale of common stock pursuant to reporting owner's 10b5-1 plan. F5 · price: This price represents the sale price of the transactions on the reported date at $353.0736. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. Read SEC document
February 01, 2021 Filed Feb 3, 2021 17:03 UTC	ABIOMED INC ABMD · Entity 121309	SaleCommon Stock, $0.01 par value	1,304	$351.97	$458,968.88	Disclosure SEC source: 0001179110-21-001224 · edgar.xml · nonDerivative · entry 3 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,070 F1 · kind: Sale of common stock pursuant to reporting owner's 10b5-1 plan. F1 · shares: Sale of common stock pursuant to reporting owner's 10b5-1 plan. F4 · price: This price represents the sale price of the transactions on the reported date at $351.9665. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. Read SEC document
February 01, 2021 Filed Feb 3, 2021 17:03 UTC	ABIOMED INC ABMD · Entity 121309	SaleCommon Stock, $0.01 par value	1,649	$351.34	$579,359.66	Disclosure SEC source: 0001179110-21-001224 · edgar.xml · nonDerivative · entry 2 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,374 F1 · kind: Sale of common stock pursuant to reporting owner's 10b5-1 plan. F1 · shares: Sale of common stock pursuant to reporting owner's 10b5-1 plan. F3 · price: This price represents the sale price of the transactions on the reported date at $351.3364. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. Read SEC document
February 01, 2021 Filed Feb 3, 2021 17:03 UTC	ABIOMED INC ABMD · Entity 121309	SaleCommon Stock, $0.01 par value	1,846	$345.64	$638,051.44	Disclosure SEC source: 0001179110-21-001224 · edgar.xml · nonDerivative · entry 1 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,023 F1 · kind: Sale of common stock pursuant to reporting owner's 10b5-1 plan. F1 · shares: Sale of common stock pursuant to reporting owner's 10b5-1 plan. F2 · price: This price represents the sale price of the transactions on the reported date at $345.6400. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. Read SEC document
December 18, 2020 Filed Dec 18, 2020 13:48 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	GrantPhantom Stock · Derivative	193	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-20-014875 · doc4.xml · derivative · entry 3 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,235 Underlying: Eaton Vance Corp. Non-voting Common Stock · 193 shares Expires not disclosed F4 · security: Each share of Phantom Stock is the economic equivalent of one share of non-voting common stock. F5 · shares: As dividends are paid with respect to Company Non-Voting Common Stock, a number of units of Phantom Stock with a current value equal to the amount of the dividend will be allocated to the account of each non-employee Director with respect to each unit of Phantom Stock Awarded at the time such dividends are paid to the stock holders of the Company. F6 · derivative.exercise_date: The shares of Phantom Stock granted on November 1, 2017 become payable in cash upon the non-employee director's termination. F6 · derivative.expiration_date: The shares of Phantom Stock granted on November 1, 2017 become payable in cash upon the non-employee director's termination. Read SEC document
December 18, 2020 Filed Dec 18, 2020 13:48 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	GrantDeferred Stock · Derivative	557	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-20-014875 · doc4.xml · derivative · entry 2 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,322 Underlying: Eaton Vance Corp. Non-voting Common Stock · 557 shares Expires not disclosed F1 · security: Each share of Deferred Stock is the economic equivalent of one share of non-voting common stock. F2 · shares: As dividends are paid with respect to Company Non-Voting Common Stock, a number of units of Deferred Stock with a current value equal to the amount of the dividend will be allocated to the account of each non-employee Director with respect to each unit of Deferred Stock Awarded at the time such dividends are paid to the stock holders of the Company. F3 · derivative.exercise_date: Shares of Deferred Stock become payable in cash based on the non-employee director's election at either (1) the earlier of the second anniversary of the grant date or the date of the non-employee director's termination, or (2) upon the non-employee director's termination. F3 · derivative.expiration_date: Shares of Deferred Stock become payable in cash based on the non-employee director's election at either (1) the earlier of the second anniversary of the grant date or the date of the non-employee director's termination, or (2) upon the non-employee director's termination. Read SEC document
November 13, 2020 Filed Nov 17, 2020 14:34 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	GrantPhantom Stock · Derivative	19	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-20-013581 · doc4.xml · derivative · entry 3 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,042 Underlying: Eaton Vance Corp. Non-voting Common Stock · 19 shares Expires not disclosed F4 · security: Each share of Phantom Stock is the economic equivalent of one share of non-voting common stock. F5 · shares: As dividends are paid with respect to Company Non-Voting Common Stock, a number of units of Phantom Stock with a current value equal to the amount of the dividend will be allocated to the account of each non-employee Director with respect to each unit of Phantom Stock Awarded at the time such dividends are paid to the stock holders of the Company. F6 · derivative.exercise_date: The shares of Phantom Stock granted on November 1, 2017 become payable in cash upon the non-employee director's termination. F6 · derivative.expiration_date: The shares of Phantom Stock granted on November 1, 2017 become payable in cash upon the non-employee director's termination. Read SEC document
November 13, 2020 Filed Nov 17, 2020 14:34 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	GrantDeferred Stock · Derivative	40	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-20-013581 · doc4.xml · derivative · entry 2 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,765 Underlying: Eaton Vance Corp. Non-voting Common Stock · 40 shares Expires not disclosed F1 · security: Each share of Deferred Stock is the economic equivalent of one share of non-voting common stock. F2 · shares: As dividends are paid with respect to Company Non-Voting Common Stock, a number of units of Deferred Stock with a current value equal to the amount of the dividend will be allocated to the account of each non-employee Director with respect to each unit of Deferred Stock Awarded at the time such dividends are paid to the stock holders of the Company. F3 · derivative.exercise_date: Shares of Deferred Stock become payable in cash based on the non-employee director's election at either (1) the earlier of the second anniversary of the grant date or the date of the non-employee director's termination, or (2) upon the non-employee director's termination. F3 · derivative.expiration_date: Shares of Deferred Stock become payable in cash based on the non-employee director's election at either (1) the earlier of the second anniversary of the grant date or the date of the non-employee director's termination, or (2) upon the non-employee director's termination. Read SEC document
November 02, 2020 Filed Nov 4, 2020 16:00 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	GrantDeferred Stock · Derivative	2,317	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-20-013014 · doc4.xml · derivative · entry 2 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,725 Underlying: Eaton Vance Corp. Non-voting Common Stock · 2,317 shares Expires not disclosed F1 · security: Each share of Deferred Stock is the economic equivalent of one share of non-voting common stock. F2 · derivative.exercise_date: Shares of Deferred Stock become payable in cash based on the non-employee director's election at either (1) the earlier of the second anniversary of the grant date or the date of the non-employee director's termination, or (2) upon the non-employee director's termination. F2 · derivative.expiration_date: Shares of Deferred Stock become payable in cash based on the non-employee director's election at either (1) the earlier of the second anniversary of the grant date or the date of the non-employee director's termination, or (2) upon the non-employee director's termination. Read SEC document
August 14, 2020 Filed Aug 14, 2020 16:04 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	GrantPhantom Stock · Derivative	30	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-20-010632 · doc4.xml · derivative · entry 3 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,023 Underlying: Eaton Vance Corp. Non-voting Common Stock · 30 shares Expires not disclosed F4 · security: Each share of Phantom Stock is the economic equivalent of one share of non-voting common stock. F5 · shares: As dividends are paid with respect to Company Non-Voting Common Stock, a number of units of Phantom Stock with a current value equal to the amount of the dividend will be allocated to the account of each non-employee Director with respect to each unit of Phantom Stock Awarded at the time such dividends are paid to the stock holders of the Company. F6 · derivative.exercise_date: The shares of Phantom Stock granted on November 1, 2017 become payable in cash upon the non-employee director's termination. F6 · derivative.expiration_date: The shares of Phantom Stock granted on November 1, 2017 become payable in cash upon the non-employee director's termination. Read SEC document
August 14, 2020 Filed Aug 14, 2020 16:04 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	GrantDeferred Stock · Derivative	63	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-20-010632 · doc4.xml · derivative · entry 2 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,408 Underlying: Eaton Vance Corp. Non-voting Common Stock · 63 shares Expires not disclosed F1 · security: Each share of Deferred Stock is the economic equivalent of one share of non-voting common stock. F2 · shares: As dividends are paid with respect to Company Non-Voting Common Stock, a number of units of Deferred Stock with a current value equal to the amount of the dividend will be allocated to the account of each non-employee Director with respect to each unit of Deferred Stock Awarded at the time such dividends are paid to the stock holders of the Company. F3 · derivative.exercise_date: Shares of Deferred Stock become payable in cash based on the non-employee director's election at either (1) the earlier of the second anniversary of the grant date or the date of the non-employee director's termination, or (2) upon the non-employee director's termination. F3 · derivative.expiration_date: Shares of Deferred Stock become payable in cash based on the non-employee director's election at either (1) the earlier of the second anniversary of the grant date or the date of the non-employee director's termination, or (2) upon the non-employee director's termination. Read SEC document
August 12, 2020 Filed Aug 14, 2020 16:07 UTC	ABIOMED INC ABMD · Entity 121309	GrantCommon Stock, $0.01 par value	661	$0.00	$0.00	Disclosure SEC source: 0001179110-20-009046 · edgar.xml · nonDerivative · entry 1 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,869 F1 · kind: Represents shares underlying the grant of restricted stock units that are to be settled in common stock upon vesting. The restricted stock units will vest in full on the earlier of: (a) August 12, 2021; or (b) the date of the Issuer's next annual meeting of stockholders. F1 · shares: Represents shares underlying the grant of restricted stock units that are to be settled in common stock upon vesting. The restricted stock units will vest in full on the earlier of: (a) August 12, 2021; or (b) the date of the Issuer's next annual meeting of stockholders. Read SEC document
August 07, 2020 Filed Aug 11, 2020 16:12 UTC	ABIOMED INC ABMD · Entity 121309	Tax withholdingCommon Stock, $0.01 par value	444	$314.98	$139,851.12	Disclosure SEC source: 0001179110-20-008877 · edgar.xml · nonDerivative · entry 1 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,208 F1 · kind: Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards F1 · shares: Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards Read SEC document
July 15, 2020 Filed Jul 17, 2020 16:02 UTC	ABIOMED INC ABMD · Entity 121309	SaleCommon Stock, $0.01 par value	7,500	$275.00	$2,062,500.00	Disclosure SEC source: 0001179110-20-008339 · edgar.xml · nonDerivative · entry 1 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,652 F1 · kind: Sale of common stock pursuant to reporting owner's 10b5-1 plan. F1 · shares: Sale of common stock pursuant to reporting owner's 10b5-1 plan. F2 · price: This price represents the sale price of the transactions on the reported date at $275.0000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. Read SEC document
June 05, 2020 Filed Jun 9, 2020 16:04 UTC	ABIOMED INC ABMD · Entity 121309	SaleCommon Stock, $0.01 par value	7,500	$250.00	$1,875,000.00	Disclosure SEC source: 0001179110-20-007123 · edgar.xml · nonDerivative · entry 1 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,152 F1 · kind: Sale of common stock pursuant to reporting owner's 10b5-1 plan. F1 · shares: Sale of common stock pursuant to reporting owner's 10b5-1 plan. F2 · price: This price represents the sale price of the transactions on the reported date at $250.0000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. Read SEC document
May 15, 2020 Filed May 15, 2020 14:26 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	GrantPhantom Stock · Derivative	34	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-20-007783 · doc4.xml · derivative · entry 3 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,993 Underlying: Eaton Vance Corp. Non-voting Common Stock · 34 shares Expires not disclosed F4 · security: Each share of Phantom Stock is the economic equivalent of one share of non-voting common stock. F5 · shares: As dividends are paid with respect to Company Non-Voting Common Stock, a number of units of Phantom Stock with a current value equal to the amount of the dividend will be allocated to the account of each non-employee Director with respect to each unit of Phantom Stock Awarded at the time such dividends are paid to the stock holders of the Company. F6 · derivative.exercise_date: The shares of Phantom Stock granted on November 1, 2017 become payable in cash upon the non-employee director's termination. F6 · derivative.expiration_date: The shares of Phantom Stock granted on November 1, 2017 become payable in cash upon the non-employee director's termination. Read SEC document
May 15, 2020 Filed May 15, 2020 14:26 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	GrantDeferred Stock · Derivative	72	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-20-007783 · doc4.xml · derivative · entry 2 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,345 Underlying: Eaton Vance Corp. Non-voting Common Stock · 72 shares Expires not disclosed F1 · security: Each share of Deferred Stock is the economic equivalent of one share of non-voting common stock. F2 · shares: As dividends are paid with respect to Company Non-Voting Common Stock, a number of units of Deferred Stock with a current value equal to the amount of the dividend will be allocated to the account of each non-employee Director with respect to each unit of Deferred Stock Awarded at the time such dividends are paid to the stock holders of the Company. F3 · derivative.exercise_date: Shares of Deferred Stock become payable in cash based on the non-employee director's election at either (1) the earlier of the second anniversary of the grant date or the date of the non-employee director's termination, or (2) upon the non-employee director's termination. F3 · derivative.expiration_date: Shares of Deferred Stock become payable in cash based on the non-employee director's election at either (1) the earlier of the second anniversary of the grant date or the date of the non-employee director's termination, or (2) upon the non-employee director's termination. Read SEC document
February 14, 2020 Filed Feb 14, 2020 16:40 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	GrantPhantom Stock · Derivative	24	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-20-002386 · doc4.xml · derivative · entry 3 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,959 Underlying: Eaton Vance Corp. Non-voting Common Stock · 24 shares Expires not disclosed F4 · security: Each share of Phantom Stock is the economic equivalent of one share of non-voting common stock. F5 · shares: As dividends are paid with respect to Company Non-Voting Common Stock, a number of units of Phantom Stock with a current value equal to the amount of the dividend will be allocated to the account of each non-employee Director with respect to each unit of Phantom Stock Awarded at the time such dividends are paid to the stock holders of the Company. F6 · derivative.exercise_date: The shares of Phantom Stock granted on November 1, 2017 become payable in cash upon the non-employee director's termination. F6 · derivative.expiration_date: The shares of Phantom Stock granted on November 1, 2017 become payable in cash upon the non-employee director's termination. Read SEC document
February 14, 2020 Filed Feb 14, 2020 16:40 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	GrantDeferred Stock · Derivative	51	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-20-002386 · doc4.xml · derivative · entry 2 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,273 Underlying: Eaton Vance Corp. Non-voting Common Stock · 51 shares Expires not disclosed F1 · security: Each share of Deferred Stock is the economic equivalent of one share of non-voting common stock. F2 · shares: As dividends are paid with respect to Company Non-Voting Common Stock, a number of units of Deferred Stock with a current value equal to the amount of the dividend will be allocated to the account of each non-employee Director with respect to each unit of Deferred Stock Awarded at the time such dividends are paid to the stock holders of the Company. F3 · derivative.exercise_date: Shares of Deferred Stock become payable in cash based on the non-employee director's election at either (1) the earlier of the second anniversary of the grant date or the date of the non-employee director's termination, or (2) upon the non-employee director's termination. F3 · derivative.expiration_date: Shares of Deferred Stock become payable in cash based on the non-employee director's election at either (1) the earlier of the second anniversary of the grant date or the date of the non-employee director's termination, or (2) upon the non-employee director's termination. Read SEC document
November 15, 2019 Filed Nov 15, 2019 15:12 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	GrantPhantom Stock · Derivative	26	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-19-014530 · doc4.xml · derivative · entry 3 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,935 Underlying: Eaton Vance Corp. Non-voting Common Stock · 26 shares Expires not disclosed F4 · security: Each share of Phantom Stock is the economic equivalent of one share of non-voting common stock. F5 · shares: As dividends are paid with respect to Company Non-Voting Common Stock, a number of units of Phantom Stock with a current value equal to the amount of the dividend will be allocated to the account of each non-employee Director with respect to each unit of Phantom Stock Awarded at the time such dividends are paid to the stock holders of the Company. F6 · derivative.exercise_date: The shares of Phantom Stock granted on November 1, 2017 become payable in cash upon the non-employee director's termination. F6 · derivative.expiration_date: The shares of Phantom Stock granted on November 1, 2017 become payable in cash upon the non-employee director's termination. Read SEC document
November 15, 2019 Filed Nov 15, 2019 15:12 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	GrantDeferred Stock · Derivative	28	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-19-014530 · doc4.xml · derivative · entry 2 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,222 Underlying: Eaton Vance Corp. Non-voting Common Stock · 28 shares Expires not disclosed F1 · security: Each share of Deferred Stock is the economic equivalent of one share of non-voting common stock. F2 · shares: As dividends are paid with respect to Company Non-Voting Common Stock, a number of units of Deferred Stock with a current value equal to the amount of the dividend will be allocated to the account of each non-employee Director with respect to each unit of Deferred Stock Awarded at the time such dividends are paid to the stock holders of the Company. F3 · derivative.exercise_date: Shares of Deferred Stock become payable in cash based on the non-employee director's election at either (1) the earlier of the second anniversary of the grant date or the date of the non-employee director's termination, or (2) upon the non-employee director's termination. F3 · derivative.expiration_date: Shares of Deferred Stock become payable in cash based on the non-employee director's election at either (1) the earlier of the second anniversary of the grant date or the date of the non-employee director's termination, or (2) upon the non-employee director's termination. Read SEC document
November 01, 2019 Filed Nov 4, 2019 16:56 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	GrantDeferred Stock · Derivative	3,034	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-19-014059 · doc4.xml · derivative · entry 2 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,194 Underlying: Eaton Vance Corp. Non-voting Common Stock · 3,034 shares Expires not disclosed F1 · security: Each share of Deferred Stock is the economic equivalent of one share of non-voting common stock. F2 · derivative.exercise_date: The shares of Deferred Stock granted on November 1, 2019 become payable in cash based on the non-employee director's election at either (1) the earlier of the second anniversary of the grant date or the date of the non-employee director's termination, or (2) upon the non-employee director's termination. F2 · derivative.expiration_date: The shares of Deferred Stock granted on November 1, 2019 become payable in cash based on the non-employee director's election at either (1) the earlier of the second anniversary of the grant date or the date of the non-employee director's termination, or (2) upon the non-employee director's termination. Read SEC document
August 15, 2019 Filed Aug 15, 2019 14:17 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	GrantPhantom Stock · Derivative	24	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-19-011422 · doc4.xml · derivative · entry 3 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,909 Underlying: Eaton Vance Corp. Non-voting Common Stock · 24 shares Expires not disclosed F4 · security: Each share of Phantom Stock is the economic equivalent of one share of non-voting common stock. F5 · shares: As dividends are paid with respect to Company Non-Voting Common Stock, a number of units of Phantom Stock with a current value equal to the amount of the dividend will be allocated to the account of each non-employee Director with respect to each unit of Phantom Stock Awarded at the time such dividends are paid to the stock holders of the Company. F6 · derivative.exercise_date: The shares of Phantom Stock granted on November 1, 2017 become payable in cash upon the non-employee director's termination. F6 · derivative.expiration_date: The shares of Phantom Stock granted on November 1, 2017 become payable in cash upon the non-employee director's termination. Read SEC document
August 15, 2019 Filed Aug 15, 2019 14:17 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	GrantDeferred Stock · Derivative	26	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-19-011422 · doc4.xml · derivative · entry 2 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,160 Underlying: Eaton Vance Corp. Non-voting Common Stock · 26 shares Expires not disclosed F1 · security: Each share of Deferred Stock is the economic equivalent of one share of non-voting common stock. F2 · shares: As dividends are paid with respect to Company Non-Voting Common Stock, a number of units of Deferred Stock with a current value equal to the amount of the dividend will be allocated to the account of each non-employee Director with respect to each unit of Deferred Stock Awarded at the time such dividends are paid to the stock holders of the Company. F3 · derivative.exercise_date: The shares of Deferred Stock granted on November 1, 2018 become payable in cash based on the non-employee director's election at either (1) the earlier of the second anniversary of the grant date or the date of the non-employee director's termination, or (2) upon the non-employee director's termination. F3 · derivative.expiration_date: The shares of Deferred Stock granted on November 1, 2018 become payable in cash based on the non-employee director's election at either (1) the earlier of the second anniversary of the grant date or the date of the non-employee director's termination, or (2) upon the non-employee director's termination. Read SEC document
August 08, 2019 Filed Aug 9, 2019 16:39 UTC	ABIOMED INC ABMD · Entity 121309	Tax withholdingCommon Stock, $0.01 par value	224	$189.93	$42,544.32	Disclosure SEC source: 0001179110-19-009350 · edgar.xml · nonDerivative · entry 2 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,652 F2 · kind: Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards. F2 · shares: Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards. Read SEC document
August 07, 2019 Filed Aug 9, 2019 16:39 UTC	ABIOMED INC ABMD · Entity 121309	GrantCommon Stock, $0.01 par value	1,053	$0.00	$0.00	Disclosure SEC source: 0001179110-19-009350 · edgar.xml · nonDerivative · entry 1 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,876 F1 · kind: Represents shares underlying the grant of restricted stock units that are to be settled in common stock upon vesting. The restricted stock units will vest in full on the earlier of: (a) August 7, 2020; or (b) the date of the Issuer's next annual meeting of stockholders. F1 · shares: Represents shares underlying the grant of restricted stock units that are to be settled in common stock upon vesting. The restricted stock units will vest in full on the earlier of: (a) August 7, 2020; or (b) the date of the Issuer's next annual meeting of stockholders. Read SEC document
May 15, 2019 Filed May 15, 2019 11:41 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	GrantPhantom Stock · Derivative	25	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-19-008031 · doc4.xml · derivative · entry 3 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,885 Underlying: Eaton Vance Corp. Non-voting Common Stock · 25 shares Expires not disclosed F4 · security: Each share of Phantom Stock is the economic equivalent of one share of non-voting common stock. F5 · shares: As dividends are paid with respect to Company Non-Voting Common Stock, a number of units of Phantom Stock with a current value equal to the amount of the dividend will be allocated to the account of each non-employee Director with respect to each unit of Phantom Stock Awarded at the time such dividends are paid to the stock holders of the Company. F6 · derivative.exercise_date: The shares of Phantom Stock granted on November 1, 2017 become payable in cash upon the non-employee director's termination. F6 · derivative.expiration_date: The shares of Phantom Stock granted on November 1, 2017 become payable in cash upon the non-employee director's termination. Read SEC document
May 15, 2019 Filed May 15, 2019 11:41 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	GrantDeferred Stock · Derivative	27	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-19-008031 · doc4.xml · derivative · entry 2 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,134 Underlying: Eaton Vance Corp. Non-voting Common Stock · 27 shares Expires not disclosed F1 · security: Each share of Deferred Stock is the economic equivalent of one share of non-voting common stock. F2 · shares: As dividends are paid with respect to Company Non-Voting Common Stock, a number of units of Deferred Stock with a current value equal to the amount of the dividend will be allocated to the account of each non-employee Director with respect to each unit of Deferred Stock Awarded at the time such dividends are paid to the stock holders of the Company. F3 · derivative.exercise_date: The shares of Deferred Stock granted on November 1, 2018 become payable in cash based on the non-employee director's election at either (1) the earlier of the second anniversary of the grant date or the date of the non-employee director's termination, or (2) upon the non-employee director's termination. F3 · derivative.expiration_date: The shares of Deferred Stock granted on November 1, 2018 become payable in cash based on the non-employee director's election at either (1) the earlier of the second anniversary of the grant date or the date of the non-employee director's termination, or (2) upon the non-employee director's termination. Read SEC document
February 15, 2019 Filed Feb 15, 2019 15:49 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	GrantPhantom Stock · Derivative	27	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-19-002737 · doc4.xml · derivative · entry 3 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,860 Underlying: Eaton Vance Corp. Non-voting Common Stock · 27 shares Expires not disclosed F4 · security: Each share of Phantom Stock is the economic equivalent of one share of non-voting common stock. F5 · shares: As dividends are paid with respect to Company Non-Voting Common Stock, a number of units of Phantom Stock with a current value equal to the amount of the dividend will be allocated to the account of each non-employee Director with respect to each unit of Phantom Stock Awarded at the time such dividends are paid to the stock holders of the Company. F6 · derivative.exercise_date: The shares of Phantom Stock granted on November 1, 2017 become payable in cash upon the non-employee director's termination. F6 · derivative.expiration_date: The shares of Phantom Stock granted on November 1, 2017 become payable in cash upon the non-employee director's termination. Read SEC document
February 15, 2019 Filed Feb 15, 2019 15:49 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	GrantDeferred Stock · Derivative	30	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-19-002737 · doc4.xml · derivative · entry 2 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,107 Underlying: Eaton Vance Corp. Non-voting Common Stock · 30 shares Expires not disclosed F1 · security: Each share of Deferred Stock is the economic equivalent of one share of non-voting common stock. F2 · shares: As dividends are paid with respect to Company Non-Voting Common Stock, a number of units of Deferred Stock with a current value equal to the amount of the dividend will be allocated to the account of each non-employee Director with respect to each unit of Deferred Stock Awarded at the time such dividends are paid to the stock holders of the Company. F3 · derivative.exercise_date: The shares of Deferred Stock granted on November 1, 2018 become payable in cash based on the non-employee director's election at either (1) the earlier of the second anniversary of the grant date or the date of the non-employee director's termination, or (2) upon the non-employee director's termination. F3 · derivative.expiration_date: The shares of Deferred Stock granted on November 1, 2018 become payable in cash based on the non-employee director's election at either (1) the earlier of the second anniversary of the grant date or the date of the non-employee director's termination, or (2) upon the non-employee director's termination. Read SEC document
November 15, 2018 Filed Nov 16, 2018 13:07 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	GrantPhantom Stock · Derivative	22	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-18-015574 · doc4.xml · derivative · entry 2 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,833 Underlying: Eaton Vance Corp. Non-voting Common Stock · 22 shares Expires not disclosed F1 · security: Each share of Phantom Stock is the economic equivalent of one share of non-voting common stock. F2 · shares: As dividends are paid with respect to Company Non-Voting Common Stock, a number of units of Phantom Stock with a current value equal to the amount of the dividend will be allocated to the account of each non-employee Director with respect to each unit of Phantom Stock Awarded at the time such dividends are paid to the stock holders of the Company. F3 · derivative.exercise_date: The shares of Phantom Stock granted on November 1, 2017 become payable in cash upon the non-employee director's termination. F3 · derivative.expiration_date: The shares of Phantom Stock granted on November 1, 2017 become payable in cash upon the non-employee director's termination. Read SEC document
November 01, 2018 Filed Nov 5, 2018 11:58 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	Exercise / conversionPhantom Stock · Derivative	2,112	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-18-015162 · doc4.xml · derivative · entry 5 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Eaton Vance Corp. Non-voting Common Stock · 2,112 shares Expires 2018-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Each share of Phantom Stock is the economic equivalent of one share of non-voting common stock. The shares of Phantom Stock become payable in cash at the earlier of the second anniversary of the grant date or the date of the non-employee director's termination. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.